SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

What is Wrong with the Gardasil Girls: Kahlia’s Story

By Leave a Comment

SEO Press Releases

North Hollywood, CA, September 13, 2010 — Norma Erickson, journalist for Examiner.com recently wrote an article about a 17 year-old from New Zealand adversely affected by Gardasil. Kahlia spent 2009 as a rotary exchange student in the United States as an active teen and an ambassador for her country. She had dreams and goals just like any adolescent girl her age. Those dreams came to a halt when Kahlia returned to New Zealand and had her first Gardasil injection.

A month later she was in the hospital. Just like other girls adversely affected by Gardasil, Kahlia had to withdraw from school. Her story is below:

On January 27, 2010, I had my first vaccination against cervical cancer. I started to experience headaches and nausea, which I did not relate to the vaccine at first. Over the next three weeks, I experienced uncontrollable mood swings, fatigue, insomnia, and clumsiness. I passed out a week before I was hospitalized.

On the night of February 27, I was hospitalized with tight, stabbing chest pains, shortness of breath, and headaches. My left leg had started spasming and I had a heavy feeling on my left side. After X-rays, ECG and blood tests all came back clear, I was sent home.

MOTHERS ALLIANCE IRELAND CALLS ON THE GOVERNMENT TO STOP THE SCHOOLS’ VACCINATION CAMPAIGN IMMEDIATELY, IN THE BEST INTERESTS OF THE NATION’S CHILDREN.

By Leave a Comment

SANE Vax.org

September 10, 2010. Mothers Alliance Ireland claims THE SCHOOLS VACCINATION CAMPAIGN, which is to be rolled out this month in Irish Schools for 12/13 year-old girls, poses a serious risk to the lives, health and welfare of Irish children, and it MUST BE ABANDONED IMMEDIATELY.

“Critical information concerning the Gardasil vaccine is being withheld from parents and the public and as a result parents are being denied the right to make a valued and fully informed decision about whether or not to consent to getting their daughters vaccinated”, said Mrs. Nora Bennis, MAI spokesperson. MAI has written to the Minister for Health and Minister for Education outlining the very serious concerns the group has about the safety, efficacy and necessity of this vaccine.

What went wrong with Gardasil

By Leave a Comment

CNN Money
September 7, 2010

FORTUNE — There’s a liquid drug that women can get injected into a layer of muscle — three separate times over a six-month period — that can protect them from a kind of cancer. From a scientific perspective, that’s amazing. In terms of public health, it’s a breakthrough.

But four years after Merck (MRK, Fortune 500) released this would-be top-seller, called Gardasil, it has proven to be a marketplace dud. In Merck’s second quarter, the company reported an 18% year-over-year drop in sales to $219 million and its stock is down nearly 3% to date. Analysts are pointing to Gardasil not as a savior, but as a risk for investors.

Cervical cancer incidence can increase despite HPV vaccination — Author's reply ( BTW- paid for by GlaxoSmithKline makers of Cervarix)

By Leave a Comment

The Lancet Infectious Diseases

Chris T Bauch
The Lancet Infectious Diseases, Volume 10, Issue 9, Page 595,
September 2010
doi:10.1016/S1473-3099(10)70183-3

Our Personal View1 presents a mathematical model to determine the conditions under which a decline in screening adherence in vaccinated women would outweigh the benefits of a human papillomvirus (HPV) immunisation programme, and thus result in a net increase in cervical cancer incidence. In their refutation, Diane Harper and colleagues’2 create a misrepresentation of our model and then refute that misrepresentation. First, Harper and colleagues interpret our model as showing that human papillomavirus (HPV) vaccination will prevent any future increase in incidence of cervical cancer. We find that such an increase is indeed possible, especially when screening coverage is high before vaccine introduction, however, it does not occur unless the decline in screening adherence is steep. Second, Harper and colleagues incorrectly cite the opportunistic screening scenario; for comparison to the situation in Finland, for which the organised screening scenario (high coverage) should be cited. Our model1 predicts that a rise in cervical cancer incidence in vaccinated women is more likely with organised screening than with opportunistic screening, and so data from Finland might actually validate our model.

News

Videos

Contact